“ GBE administration reduced mean simvastatin area under the curve (AUC)0–24, AUC0–∞ and Cmax by 39% (p = 0.000), 36%(p = 0.001) and 32% (p = 0.002), respectively, but did not cause significant differences in simvastatin acid PK or its cholesterol-lowering efficacy.”
“ GBE consumption decreased simvastatin system exposure, but did not affect simvastatin acid PK.”
“However, we cannot rule out the possibility for a pharmacodynamic interaction between GBE and simvastatin in vivo.”